Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 9—September 2011

Ciprofloxacin-Resistant Shigella sonnei among Men Who Have Sex with Men, Canada, 2010

Christiane GaudreauComments to Author , Ruwan Ratnayake, Pierre A. Pilon, Simon Gagnon, Michel Roger, and Simon Lévesque
Author affiliations: Author affiliations: Centre Hospitalier de l’Université de Montréal–Hôpital Saint-Luc, Montreal, Québec, Canada (C. Gaudreau); Université de Montréal, Montreal (C. Gaudreau, P.A. Pilon, S. Gagnon, M. Roger); Agence de la Santé et des Services Sociaux de Montréal-Santé Publique, Montreal (R. Ratnayake, P.A. Pilon); Public Health Agency of Canada, Ottawa, Ontario, Canada (R. Ratnayake); Centre Hospitalier de l’Université de Montréal–Hôpital Notre-Dame, Montreal (S. Gagnon, M. Roger); Laboratoire de Santé Publique du Québec/Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Quebec (S. Lévesque)

Main Article

Table 2

Antimicrobial drug susceptibility of Shigella sonnei isolates to 7 agents, Montreal, Québec, Canada, 2010*

Antimicrobial agent No. isolates tested MIC Interpretation
Ampicillin 11 2–8 mg/L S
TMP/SMX 11 >32 mg/L R
Ciprofloxacin 11 >4–16 mg/L R
Azithromycin 8 8–16 mg/L NA
Cefotaxime 8 0.06–0.125 mg/L S
Tetracycline 7 256–>256 mg/L R
Nalidixic acid 8 6 mm† R

*The susceptibility and resistance breakpoints were those for Enterobacteriaceae, except for azithromycin, for which these breakpoints are not available (7). TMP/SMX, trimethoprim/sulfamethoxazole; S, susceptible; R, resistant; NA, not available.
†By disk diffusion method (7).

Main Article

  1. DuPont  HL. Shigella species (Bacillary dysentery). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 7th ed. Philadelphia: Elsevier Churchill Livingston; 2010. p. 2905–10.
  2. Pazhani  GP, Niyogi  SK, Singh  AK, Sen  B, Taneja  N, Kundu  M, Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol. 2008;57:85663. DOIPubMedGoogle Scholar
  3. Centers for Disease Control and Prevention. Shigella sonnei outbreak among men who have sex with men—San Francisco, California, 2000–2001. MMWR Morb Mortal Wkly Rep. 2001;50:9226.PubMedGoogle Scholar
  4. Morgan  O, Crook  P, Cheasty  T, Jiggle  B, Giradon  I, Hughes  H, Shigella sonnei outbreak among homosexual men, London. Emerg Infect Dis. 2006;12:145860.PubMedGoogle Scholar
  5. Gaudreau  C, Bruneau  A, Ismaïl  J. Outbreak of Shigella flexneri and Shigella sonnei enterocolitis in men who have sex with men, Québec, 1999 to 2001. Can Commun Dis Rep. 2005;31:8590.PubMedGoogle Scholar
  6. Direction de santé publique, Agence de la santé et des services sociaux de Montréal. Sexual transmission of shigellosis[update 2010 Aug 9] [cited 2011 Mar 9].
  7. Clinical and Laboratory Standards Institute. Antimicrobial susceptibility testing: twentieth informational supplement; no. M100–S20 Vol. 30 No. 1. Wayne (PA): The Institute; 2010.
  8. Ribot  EM, Fair  MA, Gautom  R, Cameron  DN, Hunter  SB, Swaminathan  B, Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:5967. DOIPubMedGoogle Scholar
  9. Tenover  FC, Arbeit  RD, Goering  RV, Mickelsen  PA, Murray  BE, Persing  DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:22339.PubMedGoogle Scholar
  10. Hunter  SB, Vauterin  P, Lambert-Fair  MA, Van Duyne  MS, Kubota  K, Graves  L, Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol. 2005;43:104550. DOIPubMedGoogle Scholar
  11. Chu  YW, Cheung  TK, Wong  CH, Tsang  GK, Lee  K, Lau  SS, Quinolone resistance and correlation to other antimicrobial resistances in faecal isolates of Escherichia coli in Hong Kong. Chemotherapy. 2008;54:2748. DOIPubMedGoogle Scholar
  12. Centers for Disease Control and Prevention. 2010. National Antimicrobial Resistance Monitoring System—enteric bacteria (NARMS) 2009 annual report [cited 2011 Jun 29].
  13. Martin  LJ, Flint  J, Ravel  A, Dutil  L, Doré  K, Louie  M, Antimicrobial resistance among Salmonella and Shigella isolates in five Canadian provinces (1997 to 2000). Can J Infect Dis Med Microbiol. 2006;17:24350.PubMedGoogle Scholar
  14. Wong  MR, Reddy  V, Hanson  H, Johnson  KM, Tsoi  B, Cokes  C, Antimicrobial resistance trends of Shigella serotypes in New York City, 2006–2009. Microb Drug Resist. 2010;16:15561. DOIPubMedGoogle Scholar
  15. Centers for Disease Control and Prevention. Emergence of Shigella flexneri 2a resistant to ceftriaxone and ciprofloxacin—South Carolina, October 2010. MMWR Morb Mortal Wkly Rep. 2010;59:1619.PubMedGoogle Scholar

Main Article

Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.